Scholarlink

<p>Lymph node (LN) metastasis is a common feature of gastric adenocarcinoma (GAC) and is closely associated with a poor prognosis. Our previous study highlighted the pivotal role of nicotinamide N-methyltransferase (NNMT) in driving GAC carcinogenesis and malignant progression, primarily through its regulation of histone methylation. However, the mechanisms by which NNMT contributes to LN metastasis in GAC remain poorly understood. In this study, we demonstrated that elevated NNMT expression was positively correlated with LN metastasis and a poor prognosis in GAC patients. Gain- and loss-of-function experiments further revealed that NNMT accelerated GAC-related lymphangiogenesis, migration, and invasion in vitro and facilitated LN metastasis in vivo. Mechanistically, NNMT promoted the degradation of NR4A3 mRNA by diminishing its m<sup>6</sup>A methylation, which diminished the binding of NR4A3 protein to the promoters of fibroblast growth factor 2 (FGF2) and hepatocyte growth factor (HGF), leading to increased expression of FGF2 and HGF, which in turn enhanced lymphangiogenesis and facilitated lymphatic metastasis in GAC. Collectively, our findings suggest that NNMT plays an oncogenic role in GAC and may serve as a valuable prognostic biomarker and therapeutic target for treating LN-metastatic GAC.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

NNMT-mediated N6-methyladenosine modification of NR4A3 mRNA facilitates lymphatic metastasis of gastric adenocarcinoma

  • 期刊论文

  • 发表日期：

    2025年6月16日

查看全文
  • Xiaoya Zhao,
  • Linsen Bao,
  • Yun Qian,
  • Shimeng Zhou,
  • Chen Chen,
  • Zhuang Ma,
  • Jiawen Xu,
  • Mengmeng Li,
  • Wenlu Niu,
  • Bo Wang,
  • Qiang Wang,
  • Zhangding Wang,
  • Shouyu Wang,
  • Meng Wang

摘要

Lymph node (LN) metastasis is a common feature of gastric adenocarcinoma (GAC) and is closely associated with a poor prognosis. Our previous study highlighted the pivotal role of nicotinamide N-methyltransferase (NNMT) in driving GAC carcinogenesis and malignant progression, primarily through its regulation of histone methylation. However, the mechanisms by which NNMT contributes to LN metastasis in GAC remain poorly understood. In this study, we demonstrated that elevated NNMT expression was positively correlated with LN metastasis and a poor prognosis in GAC patients. Gain- and loss-of-function experiments further revealed that NNMT accelerated GAC-related lymphangiogenesis, migration, and invasion in vitro and facilitated LN metastasis in vivo. Mechanistically, NNMT promoted the degradation of NR4A3 mRNA by diminishing its m6A methylation, which diminished the binding of NR4A3 protein to the promoters of fibroblast growth factor 2 (FGF2) and hepatocyte growth factor (HGF), leading to increased expression of FGF2 and HGF, which in turn enhanced lymphangiogenesis and facilitated lymphatic metastasis in GAC. Collectively, our findings suggest that NNMT plays an oncogenic role in GAC and may serve as a valuable prognostic biomarker and therapeutic target for treating LN-metastatic GAC.